Total revenue increased 18.7% to $663.3 million for the fourth quarter and 18.2% to $2,621.0 million for the year Net income increased 57.0% to $37.2 million for the fourth quarter and 105.3% to $156.2 million for the year Diluted EPS increased to $0.17 for the fourth quarter and $0.74…
Month: February 2025
DELRAY BEACH, Fla., Feb. 27, 2025 /PRNewswire/ — The report “Mining Lubricants Market by Product Type (Engine Oil, Hydraulic & Transmission Oil, Gear Oil & Grease), Mining Techniques (Surface, Underground Mining), End-use Industry (Coal Mining, Iron Ore Mining), Lubricant Type, & Region…
Bringing institutional-grade investment strategies on-chain, Margarita Finance’s AI-powered agent autonomously trades derivatives with full transparency. This world-first innovation enhances efficiency and lowers the barrier to entry for sophisticated trading in decentralized finance….
VAUGHAN, ON, Feb. 27, 2025 /PRNewswire/ – GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) (“GFL” or the “Company”), a leading North American diversified environmental services company, is hosting an Investor Day today in New York City. The event is scheduled to begin at 9:00 am Eastern Time…
VAUGHAN, ON, Feb. 27, 2025 /PRNewswire/ – GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) (“GFL” or the “Company”) today announced that the Toronto Stock Exchange (“TSX”) has accepted the Company’s notice of intention to commence a normal course issuer bid (the “NCIB”) for the 12-month…
Leading presettlement funding firm renews focus on plaintiffs who’ve been unlawfully terminated due to racial, age, or sexual discrimination or sexual harassment in the workplace. LOS ANGELES, Feb. 27, 2025 /PRNewswire/ — Legal-Bay, the premier lawsuit funding company, reports today that…
CHANDLER, Ariz., Feb. 27, 2025 /PRNewswire/ — VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced a strategic partnership between VIAVI Automated Lab-as-a-Service for Open RAN (VALOR™) and the Acceleration of Compatibility and Commercialization for Open RAN Deployments (ACCoRD)…
Topline pivotal data expected in 2025 for both TKI pre-treated ROS1-positive and TKI pre-treated ALK-positive NSCLC populations First NDA submission planned for mid-year 2025 towards potential first approval in 2026 for zidesamtinib in TKI pre-treated ROS1-positive NSCLC population…
CALGARY, AB, Feb. 27, 2025 /PRNewswire/ – Veren Inc. (“Veren” or the “Company”) (TSX: VRN) (NYSE: VRN) is pleased to announce its operating and financial results for the fourth quarter and full year ended December 31, 2024. KEY HIGHLIGHTS Generated significant excess cash flow of $642…
LONDON, Feb. 27, 2025 /PRNewswire/ — Assembly, the global media agency within the Stagwell (NASDAQ: STGW) network, announced today that industry trailblazer and Europe CEO Matt Adams has been elevated to Global Chief Operating Officer. Media veteran and Europe Chief of Staff Clare…
